[Transcatheter arterial embolization/chemoembolization]. 2001

H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
Department of Radiology, Nara Medical University.

UI MeSH Term Description Entries
D007459 Iodized Oil A preparation of oil that contains covalently bound IODINE. It is commonly used as a RADIOCONTRAST AGENT and as a suspension medium for CHEMOTHERAPEUTIC AGENTS. Oil, Iodized,Iodized Oils,Iodolipol,Oils, Iodized
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D006499 Hepatic Artery A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. Arteries, Hepatic,Artery, Hepatic,Hepatic Arteries
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016461 Chemoembolization, Therapeutic Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm. Therapeutic Chemoembolization,Chemoembolizations, Therapeutic,Therapeutic Chemoembolizations
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
May 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
January 2010, Hepato-gastroenterology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
August 1986, Zhonghua fang she xue za zhi Chinese journal of radiology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
July 1974, Radiology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
September 1976, Radiology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
December 2007, World journal of gastroenterology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
November 2009, AJR. American journal of roentgenology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
August 2009, Clinical radiology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
January 1989, Cancer chemotherapy and pharmacology,
H Sakaguchi, and H Uchida, and T Tanaka, and H Anai, and K Yamamoto, and K Kichikawa, and H Ohishi
December 2000, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel,
Copied contents to your clipboard!